BioCentury
ARTICLE | Company News

Weill Cornell Medical College, Annapurna Therapeutics deal

January 11, 2016 8:00 AM UTC

Weill granted Annapurna an exclusive license to three preclinical gene therapy programs for alpha-1 antitrypsin deficiency (AATD), hereditary angioedema (HAE) and severe allergies. Annapurna expects t...